Issue 001 | U.S. Pilot | US

RKDA

Arcadia Biosciences, Inc.

Screen state: Passing Source state: Verified 10-Q | 2026-05-14 Filing currency: USD

Open Filing Back to Register Report a correction

Internal NCAV Discount 48.4%

GNNI internal NCAV discount calculation. Market context inputs are retained internally and are not displayed.

Current Assets: 5,169,000USD
Total Liabilities: 2,438,000USD
NCAV: 2,731,000USD
Cash: 954,000USD
NCAV per share: 1.33USD/share
Evidence: 10 annual | 20 quarterly

Mary filing review

Financial Statement Evidence

Deterministic observations from the frozen Mary Reason Card. They annotate filing evidence and do not determine screen inclusion.

Not captured in this issue’s Mary run.

This archived issue is not backfilled with observations from a later screening run.

Business Profile

Published only when a substantive filing-text profile has been prepared for this issue.

Not available for this issue.

A substantive filing-text profile was not prepared for this company. Financial statement evidence and filing links remain available above for direct inspection.

Historical values can be viewed as reported in each filing or normalized to the latest verified split basis. These are measurement aids, not conclusions about a company.

Policy: normalize_to_latest_verified_split_basis | quality: verified

Display basis Normalized to latest verified split basis As reported in each filing

Metric	2026-03-31 10-Q Open filing	2025-12-31 10-K Open filing	2025-09-30 10-Q Open filing	2025-06-30 10-Q Open filing	2025-03-31 10-Q Open filing	2024-12-31 10-K Open filing	2024-09-30 10-Q Open filing	2024-06-30 10-Q Open filing	2024-03-31 10-Q Open filing	2023-12-31 10-K Open filing	2023-09-30 10-Q Open filing	2023-06-30 10-Q Open filing	2023-03-31 10-Q Open filing	2022-12-31 10-K Open filing	2022-09-30 10-Q Open filing	2022-06-30 10-Q Open filing	2022-03-31 10-Q Open filing	2021-12-31 10-K Open filing	2021-09-30 10-Q Open filing	2021-06-30 10-Q Open filing	2020-12-31 10-K Open filing	2019-12-31 10-K Open filing	2018-12-31 10-K Open filing	2017-12-31 10-K Open filing	2016-12-31 10-K Open filing
Period-end Shares Outstanding	2,056,8842,056,884	n/an/a	1,367,4291,367,429	1,367,0401,367,040	1,367,0401,367,040	n/an/a	34,1241,364,940	34,0711,362,840	34,0711,362,840	n/an/a	27,7581,110,337	27,7111,108,432	21,439857,572	n/an/a	15,40224,642,960	13,86822,188,918	13,86822,188,918	n/an/a	13,86522,184,235	13,85222,163,650	8,40713,450,861	5,4048,646,149	2,9844,774,919	1,3342,134,154	1,39044,487,678
Weighted-average Basic Shares	2,082,8872,082,887	1,368,0571,368,057	1,367,1921,367,192	n/an/a	1,366,0601,366,060	n/an/a	34,0941,363,753	34,0711,362,840	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	13,59121,745,403	13,86722,186,993	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a
Weighted-average Diluted Shares	2,082,8872,082,887	n/an/a	1,371,8791,371,879	1,367,0401,367,040	1,366,2031,366,203	1,363,3031,363,303	n/an/a	n/an/a	34,0411,361,657	30,9231,236,934	33,9881,359,511	33,9601,358,395	21,610864,391	14,985599,389	15,34524,552,543	13,86822,188,918	13,86722,186,993	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a
Basic EPS	-2-2	-2-2	-1-1	-3-3	22	-5-5	-2-2	-1-1	-2-2	-11-11	-9-9	-8-8	-11-11	-26-26	-0-0	-0-0	-0-0	-28-28	-0-0	-0-0	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a
Diluted EPS	-2-2	-2-2	-1-1	-3-3	22	-5-5	-2-2	-1-1	-2-2	-11-11	-9-9	-8-8	-11-11	-26-26	-0-0	-0-0	-0-0	-28-28	-0-0	-0-0	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a
Basic-to-Diluted Share Difference	0.0%	Insufficient evidence	0.3%	Insufficient evidence	0.0%	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	2.0%	0.0%	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence
Net Share Count Change	Insufficient evidence	0.1%	0.0%	0.0%	Insufficient evidence	Insufficient evidence	0.2%	0.0%	Insufficient evidence	Insufficient evidence	0.2%	29.3%	Insufficient evidence	Insufficient evidence	11.1%	0.0%	Insufficient evidence	Insufficient evidence	0.1%	64.8%	55.6%	81.1%	123.7%	-4.1%	Insufficient evidence
Ownership Claim Change	Insufficient evidence	-0.1%	-0.0%	0.0%	Insufficient evidence	Insufficient evidence	-0.2%	0.0%	Insufficient evidence	Insufficient evidence	-0.2%	-22.6%	Insufficient evidence	Insufficient evidence	-10.0%	0.0%	Insufficient evidence	Insufficient evidence	-0.1%	-39.3%	-35.7%	-44.8%	-55.3%	4.2%	Insufficient evidence

Verified split events: reverse 20.0 on 2018-01-23; reverse 40.0 on 2023-02-27; reverse 40.0 on 2024-12-31

Known Unknowns

Medium | Share Count

The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric	2025-12-31 10-K USD	2024-12-31 10-K USD	2023-12-31 10-K USD	2022-12-31 10-K USD	2021-12-31 10-K USD	2020-12-31 10-K USD	2019-12-31 10-K USD	2018-12-31 10-K USD	2017-12-31 10-K USD	2016-12-31 10-K USD
Revenue	4,858,000	5,045,000	5,330,000	9,956,000	6,780,000	8,034,000	1,169,000	1,464,000	4,026,000	3,188,000
Operating Income	-2,500,000	-3,648,000	-13,938,000	-18,815,000	-35,526,000	-12,778,000	-19,381,000	-16,870,000	-14,315,000	-18,620,000
Net Income	-2,339,000	-7,038,000	-13,981,000	-15,376,000	-14,660,000	-4,655,000	-28,805,000	-13,480,000	-15,707,000	-19,624,000
Cash From Operations	-4,739,000	-9,627,000	-15,294,000	-13,977,000	-25,868,000	-30,218,000	-17,198,000	-13,631,000	-13,965,000	-17,055,000
Capex	0	-16,000	-5,000	-72,000	-1,007,000	-2,335,000	-1,477,000	-250,000	-79,000	-231,000
Free Cash Flow	-4,739,000	-9,643,000	-15,299,000	-14,049,000	-26,875,000	-32,553,000	-18,675,000	-13,881,000	-14,044,000	-17,286,000
Cash And Equivalents	259,000	4,242,000	6,518,000	20,644,000	28,685,000	14,042,000	8,417,000	11,998,000	9,125,000	2,013,000
Accounts Receivable	n/a	n/a	n/a	n/a	1,370,000	1,406,000	602,000	165,000	1,231,000	349,000
Inventory	1,212,000	904,000	1,958,000	2,571,000	4,433,000	3,812,000	1,794,000	181,000	229,000	252,000
Total Current Assets	6,356,000	9,242,000	14,972,000	25,398,000	35,388,000	31,696,000	28,440,000	22,876,000	15,047,000	52,222,000
Total Assets	6,546,000	13,517,000	19,705,000	28,922,000	43,918,000	47,348,000	32,574,000	24,024,000	16,570,000	56,574,000
Total Current Liabilities	2,059,000	2,563,000	3,590,000	4,209,000	5,040,000	6,314,000	5,708,000	3,054,000	3,525,000	3,129,000
Total Liabilities	2,406,000	7,294,000	7,002,000	8,022,000	12,722,000	18,796,000	24,248,000	11,209,000	8,563,000	34,376,000
Shareholders Equity	4,140,000	6,223,000	12,841,000	21,033,000	31,093,000	27,725,000	7,705,000	12,815,000	8,007,000	22,198,000
Shares Outstanding	2,056,884	1,367,040	34,071	21,439	13,868	13,335	5,409	2,986	1,335	1,391
Shares Outstanding Diluted	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Weighted Avg Shares Diluted	1,368,057	1,363,303	30,923	14,985	13,300	6,224	3,977	2,354	1,348	1,386
Weighted Avg Shares Basic	1,368,057	1,363,303	30,923	14,985	13,300	6,224	3,977	2,354	1,348	1,386
Net Share Count Change (Normalized)	0.1%	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	55.6%	81.1%	123.7%	-4.1%	Insufficient evidence
Ownership Claim Change (Normalized)	-0.1%	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	-35.7%	-44.8%	-55.3%	4.2%	Insufficient evidence

Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Metric	2026-03-31 10-Q USD	2025-12-31 10-K USD	2025-09-30 10-Q USD	2025-06-30 10-Q USD	2025-03-31 10-Q USD	2024-12-31 10-K USD	2024-09-30 10-Q USD	2024-06-30 10-Q USD	2024-03-31 10-Q USD	2023-12-31 10-K USD	2023-09-30 10-Q USD	2023-06-30 10-Q USD	2023-03-31 10-Q USD	2022-12-31 10-K USD	2022-09-30 10-Q USD	2022-06-30 10-Q USD	2022-03-31 10-Q USD	2021-12-31 10-K USD	2021-09-30 10-Q USD	2021-06-30 10-Q USD
Revenue	1,100,000	901,000	1,302,000	1,455,000	1,200,000	947,000	1,537,000	1,306,000	1,255,000	835,000	1,597,000	1,389,000	1,509,000	1,000,000	1,878,000	3,858,000	3,220,000	2,171,000	2,376,000	1,405,000
Operating Income	-779,000	-1,377,000	-1,152,000	-501,000	530,000	-804,000	-1,760,000	1,980,000	-3,064,000	-2,857,000	-3,242,000	-3,791,000	-4,048,000	-5,829,000	-4,580,000	-3,783,000	-4,623,000	-13,805,000	-8,713,000	-7,682,000
Net Income	-4,385,000	-1,336,000	856,000	-4,458,000	2,599,000	-4,064,000	-1,612,000	1,061,000	-2,423,000	-2,853,000	-2,567,000	823,000	-9,384,000	-4,244,000	-2,867,000	-3,777,000	-4,488,000	-9,282,000	-2,175,000	-5,261,000
Cash From Operations	-1,099,000	-861,000	-257,000	-2,033,000	-1,588,000	-2,209,000	-1,752,000	-2,456,000	-3,210,000	-4,145,000	-2,885,000	-4,798,000	-3,466,000	-2,356,000	-3,371,000	-3,365,000	-4,885,000	-6,660,000	-8,268,000	-6,233,000
Capex	n/a	0	0	0	0	0	0	-3,000	-13,000	0	0	-5,000	0	-26,000	0	-6,000	-40,000	-88,000	-206,000	-228,000
Free Cash Flow	n/a	-861,000	-257,000	-2,033,000	-1,588,000	-2,209,000	-1,752,000	-2,459,000	-3,223,000	-4,145,000	-2,885,000	-4,803,000	-3,466,000	-2,382,000	-3,371,000	-3,371,000	-4,925,000	-6,748,000	-8,474,000	-6,461,000
Cash And Equivalents	954,000	259,000	1,120,000	1,376,000	3,159,000	4,242,000	3,936,000	5,504,000	3,317,000	6,518,000	10,611,000	13,484,000	22,998,000	20,644,000	22,719,000	21,234,000	24,551,000	28,685,000	35,526,000	43,977,000
Total Current Assets	5,169,000	6,356,000	8,387,000	7,579,000	8,846,000	9,242,000	10,711,000	12,434,000	11,642,000	14,972,000	20,006,000	23,339,000	27,205,000	25,398,000	30,031,000	30,058,000	31,499,000	35,388,000	43,834,000	50,916,000
Total Liabilities	2,438,000	2,406,000	3,141,000	3,255,000	4,085,000	7,294,000	5,092,000	5,803,000	5,563,000	7,002,000	8,068,000	9,068,000	13,718,000	8,022,000	9,455,000	8,240,000	8,557,000	12,722,000	19,005,000	28,119,000
Shares Outstanding	2,056,884	2,056,884	1,373,120	1,367,040	1,367,040	1,367,040	34,124	34,071	34,071	34,071	27,758	27,711	23,760	15,402	15,402	13,871	13,868	13,868	13,865	13,859
Shares Outstanding Diluted	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Weighted Avg Shares Diluted	2,082,887	1,371,882	1,371,879	1,367,040	1,366,203	1,364,939	34,094	34,071	34,041	33,967	33,988	33,960	21,610	599,389	15,345	13,868	13,867	13,865	13,861	13,591
Weighted Avg Shares Basic	2,082,887	1,371,882	1,367,192	1,367,040	1,366,060	1,364,939	34,094	34,071	34,041	33,967	33,988	33,960	21,610	599,389	15,345	13,868	13,867	13,865	13,861	13,591
Net Share Count Change (Normalized)	Insufficient evidence	0.1%	0.0%	0.0%	Insufficient evidence	Insufficient evidence	0.2%	0.0%	Insufficient evidence	Insufficient evidence	0.2%	29.3%	Insufficient evidence	Insufficient evidence	11.1%	0.0%	Insufficient evidence	Insufficient evidence	0.1%	64.8%
Ownership Claim Change (Normalized)	Insufficient evidence	-0.1%	-0.0%	0.0%	Insufficient evidence	Insufficient evidence	-0.2%	0.0%	Insufficient evidence	Insufficient evidence	-0.2%	-22.6%	Insufficient evidence	Insufficient evidence	-10.0%	0.0%	Insufficient evidence	Insufficient evidence	-0.1%	-39.3%

Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input	Value	Source concept	Filing period	Confidence	Provenance
Current Assets	5,169,000USD	us-gaap:AssetsCurrent	2026-03-31	1.00	Data Vault \| sec/companyfacts/cik=0001469443/companyfacts.json Data Vault \| sec/companyfacts/cik=0001469443/companyfacts.json
Total Liabilities	2,438,000USD	us-gaap:Liabilities	2026-03-31	1.00	Data Vault \| sec/companyfacts/cik=0001469443/companyfacts.json Data Vault \| sec/companyfacts/cik=0001469443/companyfacts.json
Cash	954,000USD	us-gaap:CashAndCashEquivalentsAtCarryingValue	2026-03-31	1.00	Data Vault \| sec/companyfacts/cik=0001469443/companyfacts.json Data Vault \| sec/companyfacts/cik=0001469443/companyfacts.json
Shares Outstanding	2,056,884	us-gaap:CommonStockSharesOutstanding	2026-03-31	1.00	Data Vault \| sec/companyfacts/cik=0001469443/companyfacts.json Data Vault \| sec/companyfacts/cik=0001469443/companyfacts.json
NCAV	2,731,000USD	derived	2026-03-31	n/a	company-evidence-v1 \| total_current_assets - total_liabilities
NCAV per share	1.33USD	derived	2026-03-31	n/a	company-evidence-v1 \| NCAV / shares_outstanding
Internal NCAV Discount	48.4%	derived	2026-03-31	n/a	gnni_publication_pack \| internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source: Data Vault
Data Vault Root: Local evidence | The Data Vault
CIK: 0001469443
Company ID: n/a
Selected Annual Source: Data Vault | sec/companyfacts/cik=0001469443/companyfacts.json
Selected Quarterly Source: Data Vault | sec/companyfacts/cik=0001469443/companyfacts.json
Statement Extractor: companyfacts-screener-v1
View Extractor: companyfacts-screener-v1
Source Accession Count: 26
Imported At: 2026-08-15T12:52:44+00:00
Rendered At: 2026-08-16T03:29:38+00:00

Run Audit

Mary Run: 7597e71d9e0c42a48d3fa1ce89682485
Mary As Of: 2026-07-11
Accession: 0001193125-26-223990
CIK: 0001469443
Mary Filing Date: 2026-05-14
Filing Currency: USD
Internal Discount: 48.4%
Source State: Verified
Market Context: Not Displayed
Market Policy: internal_only_not_redistributed
Share Trend: Not Evaluated
Dilution: Needs Review

mary_run=7597e71d9e0c42a48d3fa1ce89682485; mary_as_of=2026-07-11; mary_filing_date=2026-05-14; mary_accession=0001193125-26-223990; mary_cik=0001469443; gnni_supporting_filing_date=2026-05-14; internal_discount=0.484084; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Report a correction Archive